HomeInsightsStock Comparison

Alkem Laboratories Ltd vs Sun Pharmaceuticals Industries Ltd Stock Comparison

Alkem Laboratories Ltd vs Sun Pharmaceuticals Industries Ltd Stock Comparison

Last Updated on: Jun 10, 2025

Key Highlights

  • The Latest Trading Price of Alkem Laboratories Ltd is ₹ 4940 as of 10 Jun 11:12.
  • The P/E Ratio of Alkem Laboratories Ltd changed from 24.7 on March 2020 to 32.9 on March 2024 . This represents a CAGR of 5.90% over 5 yearsThe P/E Ratio of Sun Pharmaceutical Industries Ltd changed from 22.5 on March 2020 to 40.6 on March 2024 . This represents a CAGR of 12.53% over 5 years.
  • The Market Cap of Alkem Laboratories Ltd changed from ₹ 27844 crore on March 2020 to ₹ 59067 crore on March 2024 . This represents a CAGR of 16.23% over 5 yearsThe Market Cap of Sun Pharmaceutical Industries Ltd changed from ₹ 84504 crore on March 2020 to ₹ 388812 crore on March 2024 . This represents a CAGR of 35.70% over 5 years.
  • The revenue of Alkem Laboratories Ltd for the Mar '25 is ₹ 3289 crore as compare to the Dec '24 revenue of ₹ 3467 crore. This represent the decline of -5.12% The revenue of Sun Pharmaceutical Industries Ltd for the Mar '25 is ₹ 13571 crore as compare to the Dec '24 revenue of ₹ 14141 crore. This represent the decline of -4.03%.
  • The ebitda of Alkem Laboratories Ltd for the Mar '25 is ₹ 537.25 crore as compare to the Dec '24 ebitda of ₹ 852.38 crore. This represent the decline of -36.97% The ebitda of Sun Pharmaceutical Industries Ltd for the Mar '25 is ₹ 3967 crore as compare to the Dec '24 ebitda of ₹ 4158 crore. This represent the decline of -4.6%.
  • The net profit of Alkem Laboratories Ltd changed from ₹ 287.81 crore to ₹ 323.01 crore over 8 quarters. This represents a CAGR of 5.94% The net profit of Sun Pharmaceutical Industries Ltd changed from ₹ 2013 crore to ₹ 2160 crore over 8 quarters. This represents a CAGR of 3.60% .
  • The Dividend Payout of Alkem Laboratories Ltd changed from 23.64 % on March 2020 to 27.37 % on March 2024 . This represents a CAGR of 2.97% over 5 yearsThe Dividend Payout of Sun Pharmaceutical Industries Ltd changed from 29.89 % on March 2020 to 113.33 % on March 2024 . This represents a CAGR of 30.55% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Alkem Laboratories Ltd

  • Headquartered in Mumbai, India, Alkem Laboratories Limited is a leading Indian pharmaceutical company with global operations.
  • The company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.
  • The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals, which it markets in India and international markets.
  • With a portfolio of more than 800 brands in India, Alkem is ranked the fifth largest pharmaceutical company in India in terms of domestic sales.
  • The company also has presence in more than 40 international markets, with the United States being its key focus market. Alkem Laboratories Limited was incorporated as a private limited company on August 8, 1973 in Patna and subsequently became a deemed public limited company on October 26, 1988.

About Sun Pharmaceutical Industries Ltd

  • Sun Pharmaceutical Industries Limited including its subsidiaries and associates is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets.
  • The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies.
  • It includes generics, branded generics, complex or difficult to make technology intensive products, over-the-counter (OTC) products, anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates.
  • The product portfolio of over 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, sprays, inhalers, drug delivery systems, ointments, creams and liquids.

Alkem Laboratories Ltd News Hub

News

Volumes spurt at Alkem Laboratories Ltd counter

Tata Technologies Ltd, Aditya Birla Fashion & Retail Ltd, Kaynes Technology India Ltd, Sun...

Read more

04 Jun 2025 11:00

News

Alkem Laboratories to conduct AGM

Alkem Laboratories announced that the 51th Annual General Meeting(AGM) of the company will...

Read more

29 May 2025 17:45

News

Board of Alkem Laboratories recommends final dividend

Alkem Laboratories announced that the Board of Directors of the Company at its meeting hel...

Read more

29 May 2025 17:27

News

Alkem Laboratories to discuss results

Alkem Laboratories will hold a meeting of the Board of Directors of the Company on 29 May ...

Read more

17 May 2025 15:23

News

Alkem MedTech acquires Bombay Ortho Industries

Alkem Laboratories announced that its wholly owned subsidiary, Alkem MedTech has completed...

Read more

17 Apr 2025 09:43

News

Alkem Labs' subsidiary concludes acquisition of 100% stake in Bombay Ortho

In February this year, Alkem Medtech had executed a binding offer outlining the terms and ...

Read more

17 Apr 2025 14:49

Sun Pharmaceutical Industries Ltd News Hub

News

Board of Sun Pharmaceutical Industries appoints director

The Board of Sun Pharmaceutical Industries at its meeting held on 22 May 2025 has approved...

Read more

23 May 2025 11:13

News

Sun Pharmaceutical Industries announces cessation of director

The Board of Sun Pharmaceutical Industries at its meeting held on 22 May 2025 has noted th...

Read more

23 May 2025 11:14

News

Sun Pharma drops after Q4 PAT slides 19% YoY to Rs 2,1450 cr

Profit before tax (PBT) jumped 15.6% YoY to Rs 3,254.35 crore in Q4 FY25. During the quart...

Read more

23 May 2025 13:48

News

Sun Pharmaceuticals Industries AGM scheduled

Sun Pharmaceuticals Industries announced that the 33th Annual General Meeting(AGM) of the ...

Read more

23 May 2025 15:37

News

Board of Sun Pharmaceuticals Industries recommends final dividend

Sun Pharmaceuticals Industries announced that the Board of Directors of the Company at its...

Read more

22 May 2025 20:47

News

Sun Pharmaceutical Industries Ltd Spurts 2.83%, BSE Healthcare index Rises 1.26%

Sun Pharmaceutical Industries Ltd rose 2.83% today to trade at Rs 1733.95. The BSE Healthc...

Read more

13 May 2025 09:30

SWOT Analysis Of Alkem Laboratories Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Sun Pharmaceutical Industries Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Alkem Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Sun Pharmaceutical Industries Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Alkem Laboratories Ltd and Sun Pharmaceutical Industries Ltd

Which company has a larger market capitalization, Alkem Laboratories Ltd or Sun Pharmaceutical Industries Ltd?

Market cap of Alkem Laboratories Ltd is 58,280 Cr while Market cap of Sun Pharmaceutical Industries Ltd is 406,519 Cr

What are the key factors driving the stock performance of Alkem Laboratories Ltd and Sun Pharmaceutical Industries Ltd?

The stock performance of Alkem Laboratories Ltd and Sun Pharmaceutical Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Alkem Laboratories Ltd and Sun Pharmaceutical Industries Ltd?

As of June 10, 2025, the Alkem Laboratories Ltd stock price is INR ₹4874.4. On the other hand, Sun Pharmaceutical Industries Ltd stock price is INR ₹1694.3.

How do dividend payouts of Alkem Laboratories Ltd and Sun Pharmaceutical Industries Ltd compare?

To compare the dividend payouts of Alkem Laboratories Ltd and Sun Pharmaceutical Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions